Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stem Cell Research -- Ignore unavailable to you. Want to Upgrade?

To: SnowShredder who wrote (88)	2/1/2005 8:35:29 AM
From: tom pope	Read Replies (1) \| Respond to of 495

PALO ALTO, Calif.--(BUSINESS WIRE)--Feb. 1, 2005--StemCells, Inc. (NASDAQ: STEM - News) today announced that it has been in communication with the U.S. Food and Drug Administration (FDA) regarding the filing of the Company's first Investigational New Drug (IND) application. The filing, announced on January 4, 2005, is for a Phase I clinical trial of StemCells' proprietary neural cell therapy product- HuCNS-in Batten disease. The FDA has orally informed the Company that it has suggestions and questions related to the proposed trial that require additional information from the Company and has placed the proposed trial on hold. Consistent with normal FDA procedures, the FDA is expected to formally communicate the precise nature of these issues in writing to StemCells within 30 days. In the interim, StemCells expects to be in active dialogue with the FDA to address the outstanding issues. It is important to note that none of the FDA's suggestions or questions are related to contaminated embryonic stem cells that have been the matter of media attention recently. StemCells, Inc. does not use embryonic stem cells, and does not use mouse feeder cells in any way in preparing its stem cells. All cells prepared by StemCells, Inc. are grown in serum-free media and do not come into contact with cells from animals.

To: SnowShredder who wrote (88)	3/8/2005 7:54:19 AM
From: SnowShredder	Read Replies (2) \| Respond to of 495

Breast Implants from Stem Cells could Help in Breast Augmentation Surgery fwiw...Best of Luck, SS expressnewsline.com >>>> Breast Implants from Stem Cells could Help in Breast Augmentation Surgery Publish Date : 2/21/2005 2:33:00 AM Source : Health Care News -------------------------------------------------------------------------------- Silicon breast implants could be replaced by tissues grown from a person's own stem cells within a decade, suggests new research. Jeremy Mao of the University of Illinois, Chicago, has grown fat tissue from human cells, using biologically compatible scaffolding. The tissue implanted into mice retained their size and shape even after four weeks, much longer than artificial implants under the same conditions, reported the New Scientist magazine. "This is a project that builds on previous knowledge to develop a stem cell material that could be useful in society. It seems promising and could soon be making an impact," Mao said. Implants grown from stem cells - embryonic cells that have the ability to develop into any specific tissue - could also be a safer option to silicon and saline implants that can rupture and also interfere with breast cancer detection. They could be aesthetically superior as well, since they keep their shape and size for longer than artificial inserts that typically shrink by 40 percent to 60 percent over many years due to spreading.